Svatava Merkle

4PUBLICATIONS
8CO-AUTHORS
Molecular targetsInnate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 11, 2026
RAS Inhibitor RMC-7977 Blocks Vascular Overgrowth of NRASQ61R Mutant Endothelial Cells.

|Apr 21, 2026
Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus.

|Jan 07, 2026
MEK Inhibition Reduces Vascular Malformations and Gene Dysregulation in NRASQ61R Human Endothelial Cells.

Sara Alharbi, Andrew Wagner, Svatava Merkle

|Feb 21, 2025
RAS Pathway Mutations and Therapeutics in Vascular Anomalies.

Sara Alharbi, Svatava Merkle, Adrienne M Hammill

Pageof 1

Frequent Collaborators

3 joint publications

Sara Alharbi

2 joint publications

Adrienne M Hammill

2 joint publications

C Griffin McDaniel

2 joint publications

Timothy D Le Cras